IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

VOR Biopharma Inc

CUSIP: 929033108 | 168 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AReprogrammed Interchange LLC1,278,11818.6%−96,657Oct 14, 2025No 13F filer matched
13D/AReprogrammed Interchange LLC1,278,118
18.6% of class · Oct 14, 2025−96,657
No 13F filer matched

Institutional Holders — Q3 2025

Johnson & Johnson53,732
0.5% of portfolio›$2.6M
StyleTurnoverLocationFiled
Johnson & Johnson
53,732$2.6M0.5%Agg GrowthVery LowNew Brunswick, NJ2026-03-18